Endovascular management of pediatric pial arteriovenous fistulas with hereditary GDF2 mutation: illustrative case
Endovascular embolization is the primary treatment choice for the majority of pediatric PAVFs, while a hereditary GDF2 mutation is considered a potential contributing factor to the formation of these malformations in children. Rivaroxaban has shown promise as an effective therapeutic option for pediatric sinus thrombosis, supported by its established safety profile. https://thejns.org/doi/10.3171/CASE24182.
Authors
- Lusheng Li (ORCID: https://orcid.org/0000-0002-7783-9635)
- Jun Tang (ORCID: https://orcid.org/0000-0002-6908-1027)
- Xuan Zhai (ORCID: https://orcid.org/0000-0002-9368-0265)
- Hao Chen (ORCID: https://orcid.org/0009-0001-6480-7976)
- Ping Liang (ORCID: https://orcid.org/0000-0002-7409-9504)
- Hui Hu
Institutions
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Neurosurgery Case Lessons
- Published
- 2024-08-26
- DOI
- https://doi.org/10.3171/case24182
- Primary Topic
- Vascular Malformations Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00